Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Studied for effects on lean mass, adipose tissue, and metabolic rate in research models
Kidney Disease Outcomes Quality Initiative
Key findings include: Dose-dependent improvements in neurological function scores at doses 2.5 ml/kg in rat models Reduced infarct volumes in middle cerebral artery occlusion (MCAO) models Enhanced functional recovery when combined with rehabilitation protocols Protection against excitotoxicity and oxidative stress in acute phase Studies using embolic stroke models showed that Cerebrolysin at 5 ml/kg significantly reduced lesion volume and improved sensorimotor outcomes when treatment began 4 hours post-stroke[8]
Review the listed components and available analytical reports before ordering
US$ 22.85
US$ 23.27
US$ 27.31
US$ 21.75
US$ 29.33
US$ 29.62
